Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Condition: Erosive Esophagitis Interventions: Drug: CJ-12420 100mg QD; Drug: Esomeprazole 40mg; Drug: CJ-12420 50mg QD Sponsor: CJ HealthCare Corporation Recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Erosive Esophagitis | Study